Delivery Order SPE2DB20D1100-SPE2DB25FE1DN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $54,189.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95 and an ultimate completion date of August 8, 2025. This is a non-set-aside, competitively awarded delivery order utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Voranigo 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $81,284.85 and an ultimate completion date of August 29, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $54,189.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Voranigo 40 mg tablets (30-count units), with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $162,569.70 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating that it was competed among all eligible vendors in the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $27,094.95. The delivery order was competitively awarded without set-aside designations on August 21, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Voranigo 40 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $54,189.90 and employs firm fixed pricing, with an ultimate completion date of September 16, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $54,189.90. The contract, which became effective on May 2, 2025, with an ultimate completion date of May 23, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $27,094.95 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on August 25, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $54,419.24 delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive, competitively awarded transaction executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1DNDelivery Order
The Defense Logistics Agency awarded a $108.4K delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Voranigo 40 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99M and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical product deliveries and is well-positioned within the DLA Medical Supply Chain as a critical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $108.4k | 9/25/25 |